Keith Crawford, MD, PhD
Director of Clinical Trials and Patient Education
PHEN
Discusses definitions and differences between PSA and PSMA
Michael J. Morris, MD
Medical Oncologist
MSKCC, Sydney Kimmel Center for Prostate Cancer
Discusses the successful VISION clinical trial.
Michael Groaning, PhD
Global Medical Affairs Lead
Amgen
Discusses Amgen’s AMG160 clinical trial.
One response to “PSMA, What It Is and Why It Matters to Prostate Cancer Patients”
I have just been diagnosed with stage 4 and I have not decided on any of the treatment options.
I’m interested in participating in a clinical trial. Can you help me?